Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
Exogenous mRNA encoding tetanus or botulinum neurotoxins expressed in Aplysia neurons.
Mochida S
,
Poulain B
,
Eisel U
,
Binz T
,
Kurazono H
,
Niemann H
,
Tauc L
.
???displayArticle.abstract???
Injection of exogenous mRNA purified from various tissue preparations into cellular translation systems such as Xenopus oocytes has allowed expression of complex proteins (e.g., receptors for neurotransmitters). No evidence for expression of injected exogenous mRNA, however, has been reported in terminally differentiated neurons. If achieved, it would allow the study of long-lasting changes of properties of nerve cells in their functional context. To obtain evidence of such expression, we chose two proteins that produce a detectable effect even at very low intracellular concentrations. Tetanus toxin and botulinum neurotoxin fulfill this criterion, being the most potent neurotoxins known. Both toxins block neurotransmitter release at nanomolar intracellular concentrations. These di-chain proteins, consisting of a light chain and a heavy chain, have recently been sequenced. Their active sites are located (or partly located) on the light chain. mRNAs encoding the light chain of either toxin were transcribed in vitro from the cloned and specifically truncated genes of Clostridium tetani and Clostridium botulinum, respectively, and injected into presynaptic cholinergic neurons of the buccal ganglia of Aplysia californica. Depression of neurotransmitter release appeared in less than 1 hr, demonstrating successful expression of foreign mRNA injected into a neuron in situ.
Ahnert-Hilger,
The tetanus toxin light chain inhibits exocytosis.
1989, Pubmed
Ahnert-Hilger,
The tetanus toxin light chain inhibits exocytosis.
1989,
Pubmed
Angus,
Oxygen dependence of omeprazole clearance and sulfone and sulfide metabolite formation in the isolated perfused rat liver.
1989,
Pubmed
Barnard,
Translation of exogenous messenger RNA coding for nicotinic acetylcholine receptors produces functional receptors in Xenopus oocytes.
1982,
Pubmed
,
Xenbase
Binz,
The complete sequence of botulinum neurotoxin type A and comparison with other clostridial neurotoxins.
1990,
Pubmed
Brewer,
Poly(A) shortening and degradation of the 3' A+U-rich sequences of human c-myc mRNA in a cell-free system.
1988,
Pubmed
Castellucci,
A quantal analysis of the synaptic depression underlying habituation of the gill-withdrawal reflex in Aplysia.
1974,
Pubmed
Dascal,
The use of Xenopus oocytes for the study of ion channels.
1987,
Pubmed
,
Xenbase
Eisel,
Tetanus toxin: primary structure, expression in E. coli, and homology with botulinum toxins.
1986,
Pubmed
Graves,
Translation is required for regulation of histone mRNA degradation.
1987,
Pubmed
Gundersen,
Messenger RNA from human brain induces drug- and voltage-operated channels in Xenopus oocytes.
,
Pubmed
,
Xenbase
Habermann,
Clostridial neurotoxins: handling and action at the cellular and molecular level.
1986,
Pubmed
Knakal,
Expression of a mammalian Na-H exchanger in muscle fibres of the giant barnacle.
,
Pubmed
Maisey,
Involvement of the constituent chains of botulinum neurotoxins A and B in the blockade of neurotransmitter release.
1988,
Pubmed
Makoff,
Expression of tetanus toxin fragment C in E. coli: high level expression by removing rare codons.
1989,
Pubmed
Marbaix,
Absence of polyadenylate segment in globin messenger RNA accelerates its degradation in Xenopus oocytes.
1975,
Pubmed
,
Xenbase
Mayer,
Membrane integration and intracellular transport of the coronavirus glycoprotein E1, a class III membrane glycoprotein.
1988,
Pubmed
Miledi,
Synthesis of chick brain GABA receptors by frog oocytes.
1982,
Pubmed
,
Xenbase
Mochida,
Light chain of tetanus toxin intracellularly inhibits acetylcholine release at neuro-neuronal synapses, and its internalization is mediated by heavy chain.
1989,
Pubmed
Poulain,
Neurotransmitter release is blocked intracellularly by botulinum neurotoxin, and this requires uptake of both toxin polypeptides by a process mediated by the larger chain.
1988,
Pubmed
Poulain,
Inhibition of transmitter release by botulinum neurotoxin A. Contribution of various fragments to the intoxication process.
1989,
Pubmed
Shaw,
A conserved AU sequence from the 3' untranslated region of GM-CSF mRNA mediates selective mRNA degradation.
1986,
Pubmed
Simpson,
Molecular pharmacology of botulinum toxin and tetanus toxin.
1986,
Pubmed
Soreq,
Biosynthesis and secretion of catalytically active acetylcholinesterase in Xenopus oocytes microinjected with mRNA from rat brain and from Torpedo electric organ.
1982,
Pubmed
,
Xenbase
Stecher,
The light chain but not the heavy chain of botulinum A toxin inhibits exocytosis from permeabilized adrenal chromaffin cells.
1989,
Pubmed
Sumikawa,
Active multi-subunit ACh receptor assembled by translation of heterologous mRNA in Xenopus oocytes.
1981,
Pubmed
,
Xenbase
Tauc,
Transmission abolished on a cholinergic synapse after injection of acetylcholinesterase into the presynaptic neurone.
1974,
Pubmed
Weller,
Chains and fragments of tetanus toxin. Separation, reassociation and pharmacological properties.
1989,
Pubmed
Wilson,
Removal of poly(A) and consequent degradation of c-fos mRNA facilitated by 3' AU-rich sequences.
1988,
Pubmed